180 Non Current Liabilities Total vs Net Debt Analysis

ATNF Stock

USD 2.15 0.68 24.03%

180 Life financial indicator trend analysis is way more than just evaluating 180 Life Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether 180 Life Sciences is a good investment. Please check the relationship between 180 Life Non Current Liabilities Total and its Net Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 180 Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Non Current Liabilities Total vs Net Debt

Non Current Liabilities Total vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of 180 Life Sciences Non Current Liabilities Total account and Net Debt. At this time, the significance of the direction appears to have almost no relationship.

The correlation between 180 Life's Non Current Liabilities Total and Net Debt is 0.17. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Net Debt in the same time period over historical financial statements of 180 Life Sciences, assuming nothing else is changed. The correlation between historical values of 180 Life's Non Current Liabilities Total and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of 180 Life Sciences are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Non Current Liabilities Total i.e., 180 Life's Non Current Liabilities Total and Net Debt go up and down completely randomly.

Correlation Coefficient

0.17

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Non Current Liabilities Total

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Most indicators from 180 Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into 180 Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 180 Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

The current Selling General Administrative is estimated to decrease to about 6.4 M. The 180 Life's current Tax Provision is estimated to increase to about (3.1 M)

	2022	2023	2024 (projected)
Research Development	2.4M	2.8M	2.7M
Depreciation And Amortization	109.0K	105.7K	102.8K

Research Development Depreciation And Amortization

180 Life fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Other Assets	Cash And Short Term Investments	Capital Surpluse	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Other Current Liab	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Stockholder Equity	Net Tangible Assets	Accounts Payable	Net Receivables	Other Current Assets	Property Plant Equipment	Short Long Term Debt Total
Total Assets		0.25	0.43	0.09	0.22	0.88	0.69	0.44	0.13	0.88	0.85	0.25	0.03	0.08	0.05	-0.08	0.17	-0.08	0.22	0.0	-0.02	0.15	0.17	0.04	0.09	0.13
Total Current Liabilities	0.25		0.84	-0.52	0.6	-0.19	0.57	0.97	0.72	0.52	-0.25	0.77	-0.17	0.62	-0.61	-0.82	0.65	-0.8	-0.2	0.65	0.47	0.75	0.91	0.56	0.77	-0.3
Total Stockholder Equity	0.43	0.84		-0.24	0.71	-0.05	0.53	0.91	0.55	0.63	-0.1	0.72	-0.05	0.47	-0.37	-0.64	0.41	-0.64	0.14	0.49	0.43	0.59	0.67	0.39	0.65	-0.06
Retained Earnings	0.09	-0.52	-0.24		-0.06	0.25	-0.63	-0.42	-0.72	-0.18	0.29	-0.37	0.39	-0.67	0.98	0.89	-0.1	0.89	0.89	-0.95	-0.87	-0.4	-0.64	-0.74	-0.85	0.91
Other Assets	0.22	0.6	0.71	-0.06		-0.14	0.32	0.63	0.0	0.59	-0.16	0.09	0.59	-0.12	-0.24	-0.43	0.68	-0.46	0.13	0.23	0.08	0.87	0.41	-0.22	0.47	0.29
Cash And Short Term Investments	0.88	-0.19	-0.05	0.25	-0.14		0.47	-0.02	-0.15	0.62	1.0	-0.11	0.04	-0.16	0.27	0.27	-0.07	0.27	0.19	-0.27	-0.24	-0.18	-0.19	-0.17	-0.26	0.19
Capital Surpluse	0.69	0.57	0.53	-0.63	0.32	0.47		0.65	0.56	0.83	0.42	0.4	-0.15	0.46	-0.68	-0.71	0.24	-0.71	-0.46	0.68	0.61	0.48	0.55	0.49	0.72	-0.51
Total Liab	0.44	0.97	0.91	-0.42	0.63	-0.02	0.65		0.69	0.65	-0.08	0.77	-0.16	0.59	-0.52	-0.76	0.64	-0.74	-0.06	0.57	0.41	0.73	0.86	0.5	0.75	-0.22
Total Current Assets	0.13	0.72	0.55	-0.72	0.0	-0.15	0.56	0.69		0.22	-0.22	0.82	-0.77	0.99	-0.71	-0.81	0.15	-0.76	-0.37	0.78	0.71	0.26	0.84	0.89	0.74	-0.74
Short Term Debt	0.88	0.52	0.63	-0.18	0.59	0.62	0.83	0.65	0.22		0.59	0.25	0.22	0.11	-0.29	-0.42	0.43	-0.43	-0.02	0.3	0.21	0.57	0.42	0.05	0.42	0.03
Common Stock	0.85	-0.25	-0.1	0.29	-0.16	1.0	0.42	-0.08	-0.22	0.59		-0.16	0.08	-0.22	0.31	0.32	-0.11	0.32	0.2	-0.31	-0.27	-0.22	-0.26	-0.21	-0.31	0.22
Other Current Liab	0.25	0.77	0.72	-0.37	0.09	-0.11	0.4	0.77	0.82	0.25	-0.16		-0.59	0.79	-0.38	-0.58	0.15	-0.55	-0.05	0.52	0.49	0.17	0.69	0.82	0.55	-0.4
Net Debt	0.03	-0.17	-0.05	0.39	0.59	0.04	-0.15	-0.16	-0.77	0.22	0.08	-0.59		-0.85	0.28	0.29	0.29	0.22	0.17	-0.36	-0.4	0.36	-0.4	-0.77	-0.22	0.65
Cash	0.08	0.62	0.47	-0.67	-0.12	-0.16	0.46	0.59	0.99	0.11	-0.22	0.79	-0.85		-0.64	-0.72	0.05	-0.67	-0.32	0.71	0.67	0.13	0.79	0.88	0.64	-0.73
Non Current Assets Total	0.05	-0.61	-0.37	0.98	-0.24	0.27	-0.68	-0.52	-0.71	-0.29	0.31	-0.38	0.28	-0.64		0.94	-0.19	0.95	0.83	-0.97	-0.88	-0.53	-0.69	-0.67	-0.91	0.84
Non Currrent Assets Other	-0.08	-0.82	-0.64	0.89	-0.43	0.27	-0.71	-0.76	-0.81	-0.42	0.32	-0.58	0.29	-0.72	0.94		-0.37	0.99	0.62	-0.95	-0.83	-0.67	-0.85	-0.69	-0.97	0.71
Common Stock Shares Outstanding	0.17	0.65	0.41	-0.1	0.68	-0.07	0.24	0.64	0.15	0.43	-0.11	0.15	0.29	0.05	-0.19	-0.37		-0.34	0.07	0.08	-0.21	0.87	0.6	-0.13	0.35	0.2
Short Term Investments	-0.08	-0.8	-0.64	0.89	-0.46	0.27	-0.71	-0.74	-0.76	-0.43	0.32	-0.55	0.22	-0.67	0.95	0.99	-0.34		0.64	-0.96	-0.85	-0.67	-0.81	-0.67	-0.97	0.69
Non Current Liabilities Total	0.22	-0.2	0.14	0.89	0.13	0.19	-0.46	-0.06	-0.37	-0.02	0.2	-0.05	0.17	-0.32	0.83	0.62	0.07	0.64		-0.76	-0.72	-0.21	-0.28	-0.52	-0.58	0.82
Other Stockholder Equity	0.0	0.65	0.49	-0.95	0.23	-0.27	0.68	0.57	0.78	0.3	-0.31	0.52	-0.36	0.71	-0.97	-0.95	0.08	-0.96	-0.76		0.95	0.45	0.69	0.77	0.92	-0.84
Net Tangible Assets	-0.02	0.47	0.43	-0.87	0.08	-0.24	0.61	0.41	0.71	0.21	-0.27	0.49	-0.4	0.67	-0.88	-0.83	-0.21	-0.85	-0.72	0.95		0.21	0.5	0.78	0.82	-0.85
Accounts Payable	0.15	0.75	0.59	-0.4	0.87	-0.18	0.48	0.73	0.26	0.57	-0.22	0.17	0.36	0.13	-0.53	-0.67	0.87	-0.67	-0.21	0.45	0.21		0.68	0.01	0.66	-0.03
Net Receivables	0.17	0.91	0.67	-0.64	0.41	-0.19	0.55	0.86	0.84	0.42	-0.26	0.69	-0.4	0.79	-0.69	-0.85	0.6	-0.81	-0.28	0.69	0.5	0.68		0.59	0.74	-0.45
Other Current Assets	0.04	0.56	0.39	-0.74	-0.22	-0.17	0.49	0.5	0.89	0.05	-0.21	0.82	-0.77	0.88	-0.67	-0.69	-0.13	-0.67	-0.52	0.77	0.78	0.01	0.59		0.67	-0.84
Property Plant Equipment	0.09	0.77	0.65	-0.85	0.47	-0.26	0.72	0.75	0.74	0.42	-0.31	0.55	-0.22	0.64	-0.91	-0.97	0.35	-0.97	-0.58	0.92	0.82	0.66	0.74	0.67		-0.69
Short Long Term Debt Total	0.13	-0.3	-0.06	0.91	0.29	0.19	-0.51	-0.22	-0.74	0.03	0.22	-0.4	0.65	-0.73	0.84	0.71	0.2	0.69	0.82	-0.84	-0.85	-0.03	-0.45	-0.84	-0.69

Click cells to compare fundamentals

180 Life Account Relationship Matchups

180 Life fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	51.9M	55.5M	62.7M	19.7M	5.3M	5.0M
Total Current Liabilities	9.6M	21.4M	19.7M	5.7M	5.1M	8.6M
Total Stockholder Equity	38.6M	30.3M	39.3M	11.3M	(127.7K)	(121.3K)
Retained Earnings	(37.5M)	(48.4M)	(68.7M)	(107.4M)	(127.3M)	(121.0M)
Cash And Short Term Investments	118.4M	83.4K	8.2M	7.0M	2.0M	1.9M
Total Liab	13.3M	25.2M	23.4M	8.3M	5.4M	5.1M
Total Current Assets	748.3K	4.0M	11.2M	8.9M	3.6M	4.0M
Common Stock	1.4K	2.6K	3.4K	375.0	54.0	51.3
Other Current Liab	2.0M	4.4M	17.2M	2.5M	1.9M	1.8M
Net Debt	3.4M	1.7M	(6.3M)	(5.6M)	(921.7K)	(967.8K)
Cash	83.4K	2.1M	8.2M	7.0M	2.0M	3.2M
Non Current Assets Total	51.1M	51.5M	51.5M	10.7M	1.6M	1.5M
Common Stock Shares Outstanding	29.0K	18.2M	82.5K	100.0K	379.1K	360.1K
Liabilities And Stockholders Equity	51.9M	25.2M	62.7M	19.7M	5.3M	5.0M
Non Current Liabilities Total	3.7M	3.8M	3.7M	2.6M	324.6K	308.4K
Other Stockholder Equity	75.9M	636.9K	107.2M	121.6M	130.1M	136.6M
Accounts Payable	4.1M	8.5M	586.6K	1.8M	2.2M	2.3M
Net Receivables	328.3K	784.6K	694.6K	621.0K	279.0K	535.8K
Other Current Assets	35.0K	14.4K	3.0M	1.3M	1.7M	1.1M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether 180 Life Sciences is a strong investment it is important to analyze 180 Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact 180 Life's future performance. For an informed investment choice regarding 180 Stock, refer to the following important reports:

How To Invest In 180

Details

Is 180 Stock a good investment?

Details

What is 180 Life's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 180 Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 180 Life. If investors know 180 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 180 Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

7.98

Return On Assets

(0.64)

Return On Equity

(3.99)

The market value of 180 Life Sciences is measured differently than its book value, which is the value of 180 that is recorded on the company's balance sheet. Investors also form their own opinion of 180 Life's value that differs from its market value or its book value, called intrinsic value, which is 180 Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 180 Life's market value can be influenced by many factors that don't directly affect 180 Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between 180 Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if 180 Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 180 Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

180 Non Current Liabilities Total vs Net Debt Analysis

Non Current Liabilities Total vs Net Debt

Non Current Liabilities Total vs Net Debt Correlation Analysis

Correlation Coefficient

Non Current Liabilities Total

Net Debt

180 Life fundamental ratios Correlations

180 Life Account Relationship Matchups

High Positive Relationship

High Negative Relationship

180 Life fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Cash And Short Term Investments
Cash	+ 0.99	Total Current Assets
Short Term Investments	+ 0.99	Non Currrent Assets Other
Non Current Assets Total	+ 0.98	Retained Earnings
Total Liab	+ 0.97	Total Current Liabilities
Short Term Investments	+ 0.95	Non Current Assets Total

Property Plant Equipment	- 0.97	Short Term Investments
Property Plant Equipment	- 0.97	Non Currrent Assets Other
Other Stockholder Equity	- 0.97	Non Current Assets Total
Other Stockholder Equity	- 0.96	Short Term Investments
Other Stockholder Equity	- 0.95	Non Currrent Assets Other
Other Stockholder Equity	- 0.95	Retained Earnings